Best Blalock–Thomas–Taussig shunt (BT Shunt) Treatment Hospitals Worldwide

Choosing Burjeel Hospital, Abu Dhabi for Blalock–Thomas–Taussig shunt (BT Shunt) gives patients access to experienced pediatric cardiac specialists, advanced operating facilities, and specialised postoperative cardiac intensive care. Established in 2012, the JCI hospital in Abu Dhabi, United Arab Emirates has 209 beds and provides comprehensive congenital heart services.

A Blalock-Thomas-Taussig Shunt (BT Shunt) may be considered when a congenital heart defect causes insufficient pulmonary blood flow and low oxygen levels. The procedure establishes a controlled connection between a systemic artery and a pulmonary artery via a vascular graft, thereby increasing blood flow to the lungs. Doctors evaluate the child's anatomy, oxygen saturation, pulmonary arteries, and overall clinical condition before surgery. After the procedure, close monitoring is required to assess oxygenation, circulation, and shunt patency.

Sheba Medical Center provides specialized Blalock–Thomas–Taussig shunt (BT Shunt) with a focus on pediatric cardiac expertise, precise shunt placement, oxygenation support, and comprehensive congenital heart care. Established in 1948, the JCI hospital is located in Ramat Gan, Israel and operates 1900 beds with modern pediatric cardiac infrastructure.

A Blalock-Thomas-Taussig Shunt is an established palliative surgical technique used to provide pulmonary blood flow in selected children with cyanotic congenital heart disease. During surgery, a conduit is positioned between a systemic artery and the pulmonary artery, allowing oxygen-poor blood to reach the lungs for oxygenation. The procedure does not correct the underlying heart defect and is commonly used as part of a staged treatment strategy. Detailed preoperative cardiac assessment and intensive postoperative monitoring help guide care and identify potential complications.

Acibadem University Hospital Atakent provides specialized Blalock–Thomas–Taussig shunt (BT Shunt) with a focus on pediatric cardiac expertise, precise shunt placement, oxygenation support, and comprehensive congenital heart care. Established in 2014, the JCI hospital is located in Istanbul, Turkey and operates 278 beds with modern pediatric cardiac infrastructure.

A Blalock-Thomas-Taussig Shunt is an established palliative surgical technique used to provide pulmonary blood flow in selected children with cyanotic congenital heart disease. During surgery, a conduit is positioned between a systemic artery and the pulmonary artery, allowing oxygen-poor blood to reach the lungs for oxygenation. The procedure does not correct the underlying heart defect and is commonly used as part of a staged treatment strategy. Detailed preoperative cardiac assessment and intensive postoperative monitoring help guide care and identify potential complications.

Iranian Hospital offers advanced Blalock-Thomas-Taussig Shunt (BT Shunt) surgery using modern pediatric cardiac surgical techniques and internationally accepted treatment protocols. Established in 1970, the hospital is located in Dubai, United Arab Emirates and has 220 beds, providing comprehensive congenital heart care for local and international patients.

A Blalock-Thomas-Taussig Shunt (BT Shunt) is a palliative cardiac procedure used in selected children with cyanotic congenital heart defects that result in inadequate pulmonary blood flow. The procedure creates an additional pathway for blood to flow from a systemic artery to the pulmonary arteries, thereby increasing blood flow to the lungs and improving oxygenation. Before surgery, children undergo detailed cardiac evaluation, including echocardiography and other imaging or catheter-based studies when required. Ongoing cardiac monitoring is essential after the procedure.

Choosing Istinye University Bahcesehir - LIV Hospital for Blalock–Thomas–Taussig shunt (BT Shunt) gives patients access to experienced pediatric cardiac specialists, advanced operating facilities, and specialised postoperative cardiac intensive care. Established in 2016, the ISO, JCI hospital in Istanbul, Turkey has 394 beds and provides comprehensive congenital heart services.

A Blalock-Thomas-Taussig Shunt (BT Shunt) may be considered when a congenital heart defect causes insufficient pulmonary blood flow and low oxygen levels. The procedure establishes a controlled connection between a systemic artery and a pulmonary artery via a vascular graft, thereby increasing blood flow to the lungs. Doctors evaluate the child's anatomy, oxygen saturation, pulmonary arteries, and overall clinical condition before surgery. After the procedure, close monitoring is required to assess oxygenation, circulation, and shunt patency.

Medical Park Goztepe Hospital offers advanced Blalock-Thomas-Taussig Shunt (BT Shunt) surgery using modern pediatric cardiac surgical techniques and internationally accepted treatment protocols. Established in 2005, the JCI hospital is located in Istanbul, Turkey and has 293 beds, providing comprehensive congenital heart care for local and international patients.

A Blalock-Thomas-Taussig Shunt (BT Shunt) is a palliative cardiac procedure used in selected children with cyanotic congenital heart defects that result in inadequate pulmonary blood flow. The procedure creates an additional pathway for blood to flow from a systemic artery to the pulmonary arteries, thereby increasing blood flow to the lungs and improving oxygenation. Before surgery, children undergo detailed cardiac evaluation, including echocardiography and other imaging or catheter-based studies when required. Ongoing cardiac monitoring is essential after the procedure.

Bai Jerbai Wadia Hospital for Children is a trusted healthcare provider for Blalock–Thomas–Taussig shunt (BT Shunt), offering specialised congenital heart surgery supported by experienced pediatric cardiologists, cardiothoracic surgeons, and intensivists, as well as modern cardiac infrastructure. Established in 1929, the AACI hospital is situated in Mumbai, India and has 350 beds.

Blalock-Thomas-Taussig Shunt is a palliative procedure designed to increase pulmonary blood flow in children with certain cyanotic congenital heart conditions. The shunt connects a systemic arterial blood supply to the pulmonary circulation, allowing additional blood to reach the lungs for oxygenation. It may be performed when native pulmonary blood flow is inadequate and is often part of a staged surgical pathway before further corrective or palliative procedures. Echocardiography, cardiac catheterisation, and other investigations may be used to plan treatment.

American Heart of Poland provides specialized Blalock–Thomas–Taussig shunt (BT Shunt) with a focus on pediatric cardiac expertise, precise shunt placement, oxygenation support, and comprehensive congenital heart care. Established in 2000, the ISO hospital is located in Ustron, Poland and operates 240 beds with modern pediatric cardiac infrastructure.

A Blalock-Thomas-Taussig Shunt is an established palliative surgical technique used to provide pulmonary blood flow in selected children with cyanotic congenital heart disease. During surgery, a conduit is positioned between a systemic artery and the pulmonary artery, allowing oxygen-poor blood to reach the lungs for oxygenation. The procedure does not correct the underlying heart defect and is commonly used as part of a staged treatment strategy. Detailed preoperative cardiac assessment and intensive postoperative monitoring help guide care and identify potential complications.

At Baskent University Istanbul Hospital, Blalock–Thomas–Taussig shunt (BT Shunt) is performed using advanced pediatric cardiac surgery techniques and individualized treatment plans based on the child's heart defect and pulmonary blood flow. Established in 1993, this JCI, ISO hospital in Istanbul, Turkey has 144 beds and provides comprehensive congenital heart disease services.

A BT Shunt may be recommended for selected infants and children with congenital heart defects in which blood flow to the lungs is significantly reduced. During the procedure, a synthetic vascular graft is placed between a systemic artery and the pulmonary artery to provide an alternative route for blood to reach the lungs. The shunt is generally used as part of staged treatment rather than as a definitive repair of the underlying heart defect. Careful postoperative monitoring helps assess oxygenation and shunt function.

Meliva Kardiolita Hospital, Vilnius provides specialized Blalock–Thomas–Taussig shunt (BT Shunt) with a focus on pediatric cardiac expertise, precise shunt placement, oxygenation support, and comprehensive congenital heart care. Established in 1998, the JCI hospital is located in Vilnius, Lithuania and operates 36 beds with modern pediatric cardiac infrastructure.

A Blalock-Thomas-Taussig Shunt is an established palliative surgical technique used to provide pulmonary blood flow in selected children with cyanotic congenital heart disease. During surgery, a conduit is positioned between a systemic artery and the pulmonary artery, allowing oxygen-poor blood to reach the lungs for oxygenation. The procedure does not correct the underlying heart defect and is commonly used as part of a staged treatment strategy. Detailed preoperative cardiac assessment and intensive postoperative monitoring help guide care and identify potential complications.

VPS Lakeshore Hospital offers advanced Blalock-Thomas-Taussig Shunt (BT Shunt) surgery using modern pediatric cardiac surgical techniques and internationally accepted treatment protocols. Established in 2003, the NABH, ISO hospital is located in Kochi, India and has 350 beds, providing comprehensive congenital heart care for local and international patients.

A Blalock-Thomas-Taussig Shunt (BT Shunt) is a palliative cardiac procedure used in selected children with cyanotic congenital heart defects that result in inadequate pulmonary blood flow. The procedure creates an additional pathway for blood to flow from a systemic artery to the pulmonary arteries, thereby increasing blood flow to the lungs and improving oxygenation. Before surgery, children undergo detailed cardiac evaluation, including echocardiography and other imaging or catheter-based studies when required. Ongoing cardiac monitoring is essential after the procedure.

Kaplan Medical Centre offers advanced Blalock-Thomas-Taussig Shunt (BT Shunt) surgery using modern pediatric cardiac surgical techniques and internationally accepted treatment protocols. Established in 1953, the JCI hospital is located in Rehovot, Israel and has 1100 beds, providing comprehensive congenital heart care for local and international patients.

A Blalock-Thomas-Taussig Shunt (BT Shunt) is a palliative cardiac procedure used in selected children with cyanotic congenital heart defects that result in inadequate pulmonary blood flow. The procedure creates an additional pathway for blood to flow from a systemic artery to the pulmonary arteries, thereby increasing blood flow to the lungs and improving oxygenation. Before surgery, children undergo detailed cardiac evaluation, including echocardiography and other imaging or catheter-based studies when required. Ongoing cardiac monitoring is essential after the procedure.

Manipal Hospital, Dwarka offers advanced Blalock-Thomas-Taussig Shunt (BT Shunt) surgery using modern pediatric cardiac surgical techniques and internationally accepted treatment protocols. Established in 2018, the NABH hospital is located in Delhi, India and has 380 beds, providing comprehensive congenital heart care for local and international patients.

A Blalock-Thomas-Taussig Shunt (BT Shunt) is a palliative cardiac procedure used in selected children with cyanotic congenital heart defects that result in inadequate pulmonary blood flow. The procedure creates an additional pathway for blood to flow from a systemic artery to the pulmonary arteries, thereby increasing blood flow to the lungs and improving oxygenation. Before surgery, children undergo detailed cardiac evaluation, including echocardiography and other imaging or catheter-based studies when required. Ongoing cardiac monitoring is essential after the procedure.

Choosing Guven Hospital for Blalock–Thomas–Taussig shunt (BT Shunt) gives patients access to experienced pediatric cardiac specialists, advanced operating facilities, and specialised postoperative cardiac intensive care. Established in 1975, the GHA hospital in Ankara, Turkey has 254 beds and provides comprehensive congenital heart services.

A Blalock-Thomas-Taussig Shunt (BT Shunt) may be considered when a congenital heart defect causes insufficient pulmonary blood flow and low oxygen levels. The procedure establishes a controlled connection between a systemic artery and a pulmonary artery via a vascular graft, thereby increasing blood flow to the lungs. Doctors evaluate the child's anatomy, oxygen saturation, pulmonary arteries, and overall clinical condition before surgery. After the procedure, close monitoring is required to assess oxygenation, circulation, and shunt patency.

netcare Linksfield Hospital is a trusted healthcare provider for Blalock–Thomas–Taussig shunt (BT Shunt), offering specialised congenital heart surgery supported by experienced pediatric cardiologists, cardiothoracic surgeons, and intensivists, as well as modern cardiac infrastructure. Established in 1991, the COHSASA hospital is situated in Johannesburg, South Africa and has 319 beds.

Blalock-Thomas-Taussig Shunt is a palliative procedure designed to increase pulmonary blood flow in children with certain cyanotic congenital heart conditions. The shunt connects a systemic arterial blood supply to the pulmonary circulation, allowing additional blood to reach the lungs for oxygenation. It may be performed when native pulmonary blood flow is inadequate and is often part of a staged surgical pathway before further corrective or palliative procedures. Echocardiography, cardiac catheterisation, and other investigations may be used to plan treatment.